Boom Or Bust? Where Will Shattuck Labs Inc (NASDAQ: STTK) Stock Go Next?

During the last session, Shattuck Labs Inc (NASDAQ:STTK)’s traded shares were 0.39 million, with the beta value of the company hitting 1.79. At the end of the trading day, the stock’s price was $1.00, reflecting an intraday loss of -0.50% or -$0.01. The 52-week high for the STTK share is $11.76, that puts it down -1076.0 from that peak though still a striking 1.0% gain since the share price plummeted to a 52-week low of $0.99. The company’s market capitalization is $47.98M, and the average intraday trading volume over the past 10 days was 0.3 million shares, and the average trade volume was 592.06K shares over the past three months.

Shattuck Labs Inc (STTK) received a consensus recommendation of Buy from analysts. That translates to a mean rating of 2.20. STTK has a Sell rating from 0 analyst(s) out of 4 analysts who have looked at this stock. 1 analyst(s) recommend to Hold the stock while 0 suggest Overweight, and 3 recommend a Buy rating for it.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free
Sponsored

Shattuck Labs Inc (NASDAQ:STTK) trade information

Shattuck Labs Inc (STTK) registered a -0.50% downside in the last session and has traded in the red over the past 5 sessions. The stock plummet -0.50% in intraday trading to $1.00, hitting a weekly high. The stock’s 5-day price performance is -18.62%, and it has moved by -21.48% in 30 days. Based on these gigs, the overall price performance for the year is -56.87%. The short interest in Shattuck Labs Inc (NASDAQ:STTK) is 2.19 million shares and it means that shorts have 1.76 day(s) to cover.

The consensus price target of analysts on Wall Street is $12, which implies an increase of 91.67% to the stock’s current value. The extremes of the forecast give a target low and a target high price of $8 and $16 respectively. As a result, STTK is trading at a discount of -1500.0% off the target high and -700.0% off the low.

Shattuck Labs Inc (STTK) estimates and forecasts

Statistics show that Shattuck Labs Inc has outperformed its competitors in share price, compared to the industry in which it operates. Shattuck Labs Inc (STTK) shares have gone down -86.58% during the last six months, with a year-to-date growth rate more than the industry average at 27.80% against 17.90.

An analysis of the company’s performance over the past 5 years shows that the company’s earnings shrunk an estimated -63.20%. While earnings are projected to return 26.00% in 2024.

STTK Dividends

Shattuck Labs Inc is due to release its next quarterly earnings in December. However, it is important to remember that the dividend yield ratio is merely an indicator meant to only serve as guidance.

Shattuck Labs Inc (NASDAQ:STTK)’s Major holders

Shattuck Labs Inc insiders own 13.41% of total outstanding shares while institutional holders control 74.68%, with the float percentage being 86.24%. FMR LLC is the largest shareholder of the company, while 109.0 institutions own stock in it. As of 2024-06-30, the company held over 7.13 million shares (or 14.1055% of all shares), a total value of $27.53 million in shares.

The next largest institutional holding, with 5.62 million shares, is of REDMILE GROUP, LLC’s that is approximately 11.1052% of outstanding shares. At the market price on 2024-06-30, these shares were valued at $21.68 million.

Also, the Mutual Funds coming in first place with the largest holdings of Shattuck Labs Inc (STTK) shares are Fidelity Advisor Biotechnology Fund and Vanguard Total Stock Market Index Fund . Data provided on Sep 30, 2024 indicates that Fidelity Advisor Biotechnology Fund owns about 1.32 shares. This amounts to just over 2.76 percent of the company’s overall shares, with a $1.33 million market value. The same data shows that the other fund manager holds slightly less at 1.31, or about 2.75% of the stock, which is worth about $1.32 million.